ACE and myocardial infarction: Pharmacologic interventions such as angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor antagonists (ARBs) and beta blockers are known to benefit patients with heart failure (HF) and reduced left ventricular ejection fraction (LVEF) complicating acute myocardial infarction (MI).